Webinar Series – Empowering PD Success: Managing Transitions to and from PD
2026-05-13 20:00 - 20:45 (Asia/Hong_Kong)
Click HERE to register now

Webinar Series – Data-Driven PD: Advancing Analytics for Better Outcomes
2026-05-20 15:00 - 15:45

AP HDF Webinar Series - Overcoming the Hurdles: A Clinical Perspective on Taiwan’s OLHDF Experience
2026-05-26 16:00 - 16:45
High-volume Online Hemodiafiltration (OLHDF) offers superior middle-molecule clearance and cardiovascular stability compared to standard dialysis. While its benefits include reduced mortality and improved metabolic profiles, implementation in Taiwan has faced significant hurdles regarding reimbursement and clinical awareness. Overcoming these barriers requires a shift in healthcare policy and a concerted effort to educate clinicians on the long-term advantages of the therapy.
Click HERE to register now

Webinar Series – Promoting Growth of PD Globally: Theory and Practice
2026-05-27 03:00 - 15:45
This webinar will start with an overview of the disparity of the use of PD in different countries and how this impacts on availability, sustainability and cost of dialysis. As co-chair of the International Home Dialysis Consortium, Edwina Brown will outline how this joint project of ISN and ISPD is contributing to the goal of implementing means to promote PD globally. This will be followed by Ahad Qayyum, deputy-chair of the ISPD International Liaison Committee, discussing practical aspects of increasing availability of PD in Pakistan and other low healthcare resource countries in Asia. At the end of this webinar, attendees will have an understanding how the goal of increasing the availability of PD requires focusing on patient empowerment, healthcare team education, developing networks round centres of excellence and political advocacy.
Click HERE to register now

Webinar Series – High-Volume HDF: Mechanisms and Advantages over Conventional Hemodialysis
2026-06-03 15:00 - 15:45
The available evidence supporting the beneficial effects of hemodiafiltration (HDF) raises important questions about the mechanisms responsible for the improved survival observed in clinical studies. Several potential contributors, including enhanced removal of middle and large uremic toxins, reduction of inflammation and oxidative stress, mitigation of intradialytic hypotension and morbidity, mitigation of endothelial damage and improved blood pressure control will be examined and discussed. By the end of this presentation, attendees will understand the key differences between HDF and conventional hemodialysis, the critical importance of fine-tuning HDF prescriptions, and the therapeutic targets that must be achieved to deliver the full clinical benefits of HDF to patients.
Click HERE to register now

Webinar Series – Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care
2026-06-10 15:00 - 15:45
Growing patient burden, rising healthcare costs, and persistent unmet needs to enhance survival outcomes and quality of life are challenges in the management of end-stage kidney disease. Despite being the prevailing modality of renal replacement therapy, conventional high-flux hemodialysis is still linked to substantial morbidity and mortality. These outcomes persist in part because the therapy predominantly relies on diffusive clearance and does not adequately address the accumulation of middle- and large-molecular-weight uremic toxins, limitations that hemodiafiltration (HDF) is specifically designed to overcome. An analysis of available data will be presented, categorizing the evidence for high-volume HDF into short-term, medium-term, and long- term outcomes and why HDF should be considered the new standard of care in dialysis.
Click HERE to register now

Webinar Series – What to be Considered While Implementing HDF With High Convection Volume
2026-06-17 15:00 - 15:45
This webinar will provide a comprehensive overview of the key considerations for implementing hemodiafiltration. We will address best practices, initial prerequisites, patient selection, and prescription parameters to achieve high-volume HDF. In addition, real-world insights from the implementation of HDF in Spain will be shared, highlighting practical lessons and outcomes.
Click HERE to register now

Webinar Series – The CONVINCE Study And its Far-Reaching Impact
2026-06-24 15:00 - 15:45
In this webinar the beneficial effects of high-volume hemodiafiltration (HDF) compared to hemodialysis, as demonstrated in the large randomized controlled CONVINCE study, will be presented. This also includes available evidence of the positive effect of HDF on patients’ health-related quality of life. Beyond CONVINCE, other potential benefits of HDF are being discussed, especially as these additional benefits are gaining increasing attention among nephrologists.
Click HERE to register now

AP HDF Webinar Series – Clinical Perspectives in Hemodiafiltration: Case-Based Insights
2026-06-25 16:00 - 17:00
In Clinical Perspectives on Hemodiafiltration: Case-Based Insights, we would be covering different case reports of HDF in various clinical settings and looking at the nuances and implications of HDF.
Click HERE to register now
